The Relationship Between Dermatologist- and Patient-Reported Acne Severity Measures and Treatment Recommendations

Abstract

French

Background:

Acne treatment recommendations for individual patients may be derived from multiple factors including dermatologist- and patient-reported constructs.

Objectives:

To evaluate the effects of dermatologist- and patient-reported measures on acne treatment recommendations by dermatologists.

Methods:

An observational cross-sectional survey of acne patients was conducted with patient-reported quality of life and dermatologist-reported measures of primary and secondary (scar) acne severity using 3 assessment approaches: maximal regional grade, total grade, and facial grade.

Results:

The most highly associated factors with acne treatment recommendations were patient emotions, maximal regional acne severity, and total acne scar grade. Better acne-specific quality of life was negatively related to acne treatment recommendation intensity, while all 3 grading approaches were positively related to acne treatment recommendations.

Conclusions:

For dermatologists, overall acne severity is most highly associated with maximal regional acne grade, total scar grade, and patient’s emotional response to acne.

Keywords

acne dermatology

Get full access to this article

View all access options for this article.

References

Strauss

Krowchuk

Leyden

. Guidelines of care for acne vulgaris management. J Am Acad Dermatol 2007;56:651-663.

Institute for Clinical Systems Improvement. ICSI Health Care Guideline: Acne Management. 3rd ed. 2006. http://www.icsi.org/knowledge.

Gollnick

Cunliffe

Berson

. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49(1 suppl):S1-S37.

Pochi

Shalita

Strauss

JS, et al

. Report of the consensus conference on acne classification. J Am Acad Dermatol. 1991;24:495-500.

Maddin

Landells

Poulin

. Treatment of acne vulgaris and prevention of acne scarring: Canadian consensus guidelines. J Cutan Med Surg. 2000(4 suppl 1):S2-S13.

Tan

JKL

Tang

Fung

. Prevalence and severity of facial and truncal acne in a referral cohort. J Drugs Dermatol. 2008;7:553-556.

Del Rosso

Bikowski

Baum

. A closer look at truncal acne vulgaris: prevalence, severity, and clinical significance. J Drugs Dermatol. 2007;6:597-600.

Thiboutot

Gollnick

Bettoli

. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol. 2009;60(5):S1-S50.

Gollnick

HPM

Finlay

Shear

. Can we define acne as a chronic disease? Am J Clin Dermatol. 2008;9(5):279-284.

10.

Thiboutot

Lookingbill

DP.

Acne: acute or chronic disease?

J Am Dermatol. 1995;32(5):S2-S5.

11.

US Food and Drug Administration. Guidance for Industry: Acne Vulgaris: Developing Drugs of Treatment. Rockville, MD: Center for Drug Evaluation and Research; 2005.

12.

Jones-Caballero

Chren

Soler

. Quality of life in mild to moderate acne: relationship to clinical severity and factors influencing change with treatment. J Eur Acad Dermatol Venereol. 2006;21(2):219-226.

13.

Martin

Lookingbill

Botek

. Health-related quality of life among patients with facial acne—assessment of a new acne-specific questionnaire. Clin Exp Dermatol. 2001;26:380-385.

14.

Girman

Hartmaier

Thiboutot

. Evaluating health-related quality of life in patients with facial acne: development of a self-administered questionnaire for clinical trials. Qual Life Res. 1996;5(5):481-490.

15.

Fehnel

McLeod

Brandman

. Responsiveness of the acne-specific quality of life questionnaire (Acne-QoL) to treatment for acne vulgaris in placebo-controlled clinical trials. Qual Life Res. 2002;11:809-816.

16.

Eichenfield

Krakowski

Piggott

. Evidence-based recommendations for the diagnosis and treatment of pediatric acne. Pediatrics. 2013;131(suppl 3):S163-S186.

17.

Nast

Dréno

Bettoli

. European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol. 2012;26(suppl 1):1-29.

18.

Masahiko

Morohashi

Pathogenesis of acne. Med Electron Microsc. 2001;34(1):29-40.

19.

Tan

JK.

The Canadian acne epidemiological survey: baseline demographics and interim analysis. J Am Acad Dermatol. 2004;50(3):P15.

20.

Tan

Fung

Khan

Condensation and validation of a 4-item index of the Acne-QoL. Qual Life Res. 2006;15(7):1203-1210.

21.

Tan

Tang

Fung

. Development and validation of a comprehensive acne severity scale. J Cutan Med Surg. 2006;11(6):211-216.

22.

Tan

JKL

Tang

Fung

. Development and validation of a Scale for Acne Scar Severity (SCAR-S) of the face and trunk. J Cutan Med Surg. 2010;14(4):156-160.

23.

Health Canada. Summary safety review—DIANE 35. April 2014. http://www.hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/review-examen/diane-35-eng.php.

24.

Tan

Wolfe

Weiss

. Acne severity grading: determining essential clinical components and features using a Delphi consensus. J Am Acad Dermatol. 2012;67(2):187-193.

25.

O’Brien

Lewis

Cunliffe

WJ.

The Leeds revised acne grading system. J Dermatol Treat. 1998;9(4):215-220.

26.

Motley

Finlay

AY.

Practical use of a disability index in the routine management of acne. Clin Exp Dermatol. 1992;17:1-3.

27.

Mulder

MMS

Sigurdsson

van Zuuren

. Psychosocial impact of acne vulgaris. Dermatology. 2001;203:124-130.

28.

Law

Chuh

Lee

. Acne prevalence and beyond: acne disability and its predictive factors among Chinese late adolescents in Hong Kong. Clin Exp Dermatol. 2010;35:16-21.

29.

Ghodsi

Orawa

Zouboulis

CC.

Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study. J Invest Dermatol. 2009;129:2136-2141.

30.

Dréno

Recent data on epidemiology of acne. Ann Dermatol Venereol. 2010;137(12):3-5.

31.

Williams

Dellavalle

Garner

Acne vulgaris. J Lancet. 2012;379(9813):361-372.